EVALUATING THE RISKS OF WITHDRAWAL SYMPTOMS AND REBOUND INSOMNIA UPON DISCONTINUATION OF DARIDOREXANT IN PATIENTS WITH INSOMNIA DISORDER

被引：0
|
作者：
Leger, D. [1 ]
Fietze, I. [2 ]
Pain, S. [3 ]
Kinter, D. Seboek [3 ]
Flamion, B. [3 ]
Mignot, E. [4 ]
机构：
[1] Univ Paris 05, AP HP, Paris, France
[2] Univ Hosp, Ctr Sleep Med, Charit, Berlin, Germany
[3] Idorsia Pharmaceut Ltd, Allschwil, Switzerland
[4] Stanford Med, Ctr Narcolepsy, Palo Alto, CA USA
来源：
SLEEP MEDICINE | 2022年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [31] REBOUND INSOMNIA - POTENTIAL HAZARD FOLLOWING WITHDRAWAL OF CERTAIN BENZODIAZEPINES
    KALES, A
    SCHARF, MB
    KALES, JD
    SOLDATOS, CR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (16): : 1692 - 1695
  • [32] EFFECTS OF DARIDOREXANT ON TOTAL SLEEP TIME (TST) AND SLEEP STAGE PROPORTIONS IN PATIENTS WITH INSOMNIA DISORDER
    Zammit, G.
    Mayleben, D.
    Fietze, I.
    Pain, S.
    Gimona, A.
    Kinter, D. Seboek
    Dauvilliers, Y.
    SLEEP MEDICINE, 2022, 100 : S118 - S118
  • [33] Adis summary of research: Long-term safety and tolerability of daridorexant in patients with insomnia disorder
    Syed, Yahiya Y.
    DRUGS & THERAPY PERSPECTIVES, 2025, 41 (01) : 1 - 2
  • [34] Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine
    Dallal, A
    Chouinard, G
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (04) : 343 - 344
  • [35] PREVALENCE OF INSOMNIA SYMPTOMS AND INSOMNIA DISORDER WITHIN VA SUBACUTE REHABILITATION
    Boeve, Angelica
    Boyle, Julia
    Moye, Jennifer
    Driver, Jane
    Ruopp, Marcus
    O'Malley, Kelly
    SLEEP, 2023, 46
  • [36] PregabalinDrug misuse, drug dependence and various withdrawal symptoms including rebound insomnia: 3 case reports
    Reactions Weekly, 2022, 1891 (1) : 255 - 255
  • [37] Daridorexant, a new dual orexin receptor antagonist, in elderly subjects with insomnia disorder
    Zammit, Gary
    Dauvilliers, Yves
    Pain, Scott
    Kinter, Dalma Sebok
    Mansour, Yosef
    Kunz, Dieter
    NEUROLOGY, 2020, 94 (21) : E2222 - E2232
  • [38] DARIDOREXANT IN PATIENTS WITH INSOMNIA DISORDER: NUMBER NEEDED TO TREAT, NUMBER NEEDED TO HARM & LIKELIHOOD TO BE HELPED OR HARMED
    Chalet, Francois-Xavier
    Luyet, Pierre-Philippe
    Rabasa, Cristina
    Vaillant, Cedric
    Saskin, Paul
    Ahuja, Ajay
    Citrome, Leslie
    SLEEP, 2023, 46 : A155 - A155
  • [39] Sleep outcomes following eszopiclone discontinuation in patients with primary insomnia and insomnia co-existing with major depressive disorder or generalized anxiety disorder
    Krystal, A.
    Fava, M.
    Pollack, M.
    Rubens, R.
    Schaefer, K.
    Amato, D.
    Roth, T.
    SLEEP, 2007, 30 : A245 - A245
  • [40] REBOUND INSOMNIA AFTER DISCONTINUATION OF TRIAZOLAM - STUDY OF NORMAL HEALTHY-SUBJECTS
    TSUTSUMI, Y
    JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 1995, 17 (06): : 435 - 443
12345